Vitamin E found effective in treatment of certain Liver Diseases
PUBLIC RELEASE:
Vitamin E (d-alpha-tocopherol) is an effective treatment for
non-alcoholic steatohepatitis (NASH), according to new research. NASH occurs
when the liver becomes inflamed due to the accumulation of fat. Over time,
persistent inflammation can lead to the formation of fibrous scar tissue in the
liver and around its blood vessels, which can eventually cause
cirrhosis.Right-click here to download pictures. To help protect your privacy,
Outlook prevented automatic download of this picture from the Internet.
A pooled analysis of data from two randomised trials
comparing vitamin E versus placebo, and the placebo group from another trial
comparing vitamin E use versus non-use, demonstrates that the efficacy of
vitamin E is comparable to other treatments for NASH, including pioglitazone,
metformin and obeticholic acid. In addition, treatment with vitamin E is
associated with significant improvements in both NASH histology (45% vs 22% in
those not treated with vitamin E) and resolution of disease (38% vs 20% in those
not treated with vitamin E). There was no increase in cardiovascular events and
no adverse lipid profiles were observed with vitamin E treatment.
A total of 347 patients (155 treated with vitamin E, 192 not
treated with vitamin E) were included in the analysis which compared data from
three clinical trials that investigated the efficacy and safety of vitamin E as
a treatment for NASH: the PIVENS, TONIC and FLINT trials. Histologic
improvement was defined as ? 2 point improvement in NAS with no worsening of
fibrosis, and NASH resolution measured effectiveness.
The study supports the use of vitamin E as a treatment for
NASH.
http://www.eurekalert.org/pub_releases/2015-04/eaft-pac042215.php
No comments:
Post a Comment